Susquehanna International Group’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $23.7M | Sell |
30,620
-61,841
| -67% | -$47.3M | ﹤0.01% | 2017 |
|
|
2025
Q4 | $71.4M | Sell |
92,461
-97,715
| -51% | -$66.4M | 0.01% | 1094 |
|
|
2025
Q3 | $107M | Buy |
190,176
+26,084
| +16% | +$14.7M | 0.01% | 856 |
|
|
2025
Q2 | $86.1M | Buy |
164,092
+12,634
| +8% | +$7.05M | 0.01% | 837 |
|
|
2025
Q1 | $96.1M | Buy |
151,458
+69,266
| +84% | +$47.6M | 0.02% | 668 |
|
|
2024
Q4 | $58.5M | Buy |
82,192
+48,682
| +145% | +$40.9M | 0.01% | 1001 |
|
|
2024
Q3 | $35.2M | Buy |
33,510
+3,098
| +10% | +$3.45M | 0.01% | 1349 |
|
|
2024
Q2 | $32M | Sell |
30,412
-6,561
| -18% | -$6.36M | 0.01% | 1304 |
|
|
2024
Q1 | $35.6M | Sell |
36,973
-53,224
| -59% | -$50.6M | 0.01% | 1269 |
|
|
2023
Q4 | $79.2M | Buy |
90,197
+35,337
| +64% | +$29.1M | 0.02% | 788 |
|
|
2023
Q3 | $45.1M | Sell |
54,860
-19,157
| -26% | -$15.1M | 0.01% | 1076 |
|
|
2023
Q2 | $53.2M | Sell |
74,017
-22,187
| -23% | -$17.1M | 0.01% | 951 |
|
|
2023
Q1 | $79M | Buy |
96,204
+15,707
| +20% | +$11.8M | 0.02% | 698 |
|
|
2022
Q4 | $58.1M | Buy |
80,497
+57,355
| +248% | +$42.3M | 0.01% | 807 |
|
|
2022
Q3 | $15.9M | Sell |
23,142
-25,609
| -53% | -$16.1M | ﹤0.01% | 1637 |
|
|
2022
Q2 | $28.8M | Sell |
48,751
-12,561
| -20% | -$8.16M | 0.01% | 1177 |
|
|
2022
Q1 | $42.8M | Sell |
61,312
-114,711
| -65% | -$72.6M | 0.01% | 1089 |
|
|
2021
Q4 | $111M | Sell |
176,023
-94,140
| -35% | -$57.9M | 0.02% | 674 |
|
|
2021
Q3 | $163M | Sell |
270,163
-88,164
| -25% | -$54.7M | 0.02% | 602 |
|
|
2021
Q2 | $200M | Buy |
358,327
+144,175
| +67% | +$73M | 0.03% | 497 |
|
|
2021
Q1 | $101M | Sell |
214,152
-498,689
| -70% | -$243M | 0.02% | 728 |
|
|
2020
Q4 | $344M | Buy |
712,841
+518,331
| +266% | +$280M | 0.06% | 257 |
|
|
2020
Q3 | $109M | Buy |
194,510
+90,210
| +86% | +$54.7M | 0.02% | 538 |
|
|
2020
Q2 | $65M | Buy |
104,300
+69,067
| +196% | +$39.2M | 0.02% | 689 |
|
|
2020
Q1 | $17.2M | Sell |
35,233
-28,736
| -45% | -$11.9M | 0.01% | 1286 |
|
|
2019
Q4 | $24M | Sell |
63,969
-198,283
| -76% | -$66.7M | 0.01% | 1263 |
|
|
2019
Q3 | $72.7M | Buy |
262,252
+75,791
| +41% | +$22.4M | 0.02% | 568 |
|
|
2019
Q2 | $58.4M | Buy |
186,461
+183,150
| +5,532% | +$61M | 0.02% | 615 |
|
|
2019
Q1 | $1.36M | Buy |
3,311
+2,459
| +289% | +$1.01M | ﹤0.01% | 4413 |
|
|
2018
Q4 | $318K | Sell |
852
-4,505
| -84% | -$1.65M | ﹤0.01% | 6888 |
|
|
2018
Q3 | $2.16M | Sell |
5,357
-164,234
| -97% | -$62.5M | ﹤0.01% | 3847 |
|
|
2018
Q2 | $58.5M | Buy |
169,591
+137,780
| +433% | +$43.1M | 0.02% | 622 |
|
|
2018
Q1 | $11M | Buy |
31,811
+16,564
| +109% | +$5.76M | ﹤0.01% | 1699 |
|
|
2017
Q4 | $5.73M | Buy |
15,247
+11,447
| +301% | +$4.64M | ﹤0.01% | 2390 |
|
|
2017
Q3 | $1.7M | Buy |
3,800
+3,053
| +409% | +$1.45M | ﹤0.01% | 4210 |
|
|
2017
Q2 | $367K | Sell |
747
-1,412
| -65% | -$618K | ﹤0.01% | 7217 |
|
|
2017
Q1 | $837K | Sell |
2,159
-59,600
| -97% | -$22.1M | ﹤0.01% | 5509 |
|
|
2016
Q4 | $22.7M | Buy |
+61,759
| New | +$23.5M | 0.01% | 959 |
|
|
2016
Q3 | – | Sell |
-131,534
| Closed | -$52.8M | – | 8916 |
|
|
2016
Q2 | $45.9M | Buy |
131,534
+94,511
| +255% | +$36.4M | 0.02% | 546 |
|
|
2016
Q1 | $13.3M | Sell |
37,023
-3,281
| -8% | -$1.35M | 0.01% | 1294 |
|
|
2015
Q4 | $21.9M | Sell |
40,304
-13,489
| -25% | -$7.31M | 0.01% | 1069 |
|
|
2015
Q3 | $25M | Sell |
53,793
-86,569
| -62% | -$46.5M | 0.01% | 1035 |
|
|
2015
Q2 | $71.6M | Buy |
140,362
+37,819
| +37% | +$18.5M | 0.03% | 519 |
|
|
2015
Q1 | $46.3M | Sell |
102,543
-54,628
| -35% | -$23.2M | 0.02% | 676 |
|
|
2014
Q4 | $64.5M | Buy |
157,171
+20,850
| +15% | +$8.2M | 0.03% | 599 |
|
|
2014
Q3 | $49.1M | Sell |
136,321
-81,804
| -38% | -$27.4M | 0.02% | 762 |
|
|
2014
Q2 | $61.6M | Sell |
218,125
-43,850
| -17% | -$13M | 0.03% | 590 |
|
|
2014
Q1 | $78.7M | Buy |
261,975
+67,387
| +35% | +$20.8M | 0.04% | 435 |
|
|
2013
Q4 | $53.6M | Buy |
194,588
+23,758
| +14% | +$6.83M | 0.02% | 619 |
|
|
2013
Q3 | $53.4M | Buy |
170,830
+28,906
| +20% | +$7.6M | 0.03% | 570 |
|
|
2013
Q2 | $31.9M | Buy |
+141,924
| New | +$33M | 0.02% | 789 |
|
Other funds holding REGN
VCM
N
Susquehanna International Group's REGN Position: Q1 2026 in Review
Susquehanna International Group reduced its Regeneron Pharmaceuticals (REGN) stake by 67% in Q1 2026, selling an estimated $47.3M and leaving 30,620 shares worth $23.7M. The position accounts for ﹤0.01% of the portfolio, ranked #2017.
Susquehanna International Group first reported a position in REGN in Q2 2013 and has held it in 51 quarters since. The position peaked at $344M in Q4 2020. 1,392 funds tracked by Wall St. Rank hold REGN as of Q1 2026.
- Susquehanna International Group held 30,620 shares of Regeneron Pharmaceuticals worth $23.7M as of Q1 2026.
- Susquehanna International Group sold 61,841 Regeneron Pharmaceuticals shares in Q1 2026, an estimated $47.3M.
- Regeneron Pharmaceuticals made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #2017 holding.
- Susquehanna International Group first reported a position in Regeneron Pharmaceuticals in Q2 2013 and has held it in 51 quarters since.
- Susquehanna International Group's Regeneron Pharmaceuticals position peaked at $344M in Q4 2020.
- 1,392 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.
Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.